Monoclonal antibody share of new drug approvals
Percentage of total authorized new medicines accounted for by monoclonal antibody therapies.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2025
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 2025 NMPA Approvals: China Clears Record Number of New Drugs | DIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Monoclonal antibody share of new drug approvals. Retrieved from https://statorigin.org/indicators/monoclonal-antibody-share-of-new-drug-approvals